弥漫性胶质瘤切除术后早期静脉血栓栓塞:诊断与预防意义
该回顾性单中心队列分析纳入2021至2023年81例弥漫性胶质瘤切除患者,术后第1天筛查D-二聚体和可溶性纤维蛋白单体复合物(SFMC)诊断VTE。33例(40.7%)诊断VTE,其中31例无症状;D-二聚体、SFMC及联合的阳性预测值分别为83%、68%、69%;无症状VTE未进展为症状性。
要点
- 弥漫性胶质瘤切除术后第1天无症状VTE发生率高(40.7%)。
- D-二聚体阳性预测值83%,SFMC未改善D-二聚体假阳性。
- SFMC可提高胶质母细胞瘤患者的VTE检出率。
核心结论
- 弥漫性胶质瘤切除术后第1天无症状VTE常见,早期诊断可防止进展为症状性VTE。
研究设计与样本
- 回顾性单中心队列分析,纳入2021至2023年81例接受弥漫性胶质瘤切除术的患者。
主要发现
- 81例中33例(40.7%)诊断VTE,其中31例无症状。
- D-二聚体、SFMC及两者联合的阳性预测值分别为83%、68%、69%。
- 12例D-二聚体假阴性中,SFMC检出3例VTE,均为胶质母细胞瘤(另9例为非胶质母细胞瘤)。
- 无症状VTE无一进展为症状性VTE。
关键数值与推荐
- 术后第1天通过D-二聚体和SFMC水平筛查VTE,经胸腹下肢增强CT诊断。
- 无症状VTE采用机械预防,开颅术后1周开始抗凝治疗。
临床怎么用
- 术后第1天应筛查VTE,尤其关注无症状患者。
- D-二聚体阳性预测值较高,SFMC对胶质母细胞瘤患者有补充诊断价值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Patients undergoing glioma resection are at high risk for venous thromboembolism (VTE), making early diagnosis and prevention critical. This retrospective single-institutional cohort analysis investigated the incidence of VTE on postoperative day (POD) 1 after diffuse glioma resection, screening effectiveness of plasma soluble fibrin monomer complex (SFMC) and D-dimer levels, and management outcomes. METHODS: A total of 81 patients who underwent diffuse glioma resection at our institution from 2021 to 2023 were analyzed. VTE was screened by D-dimer and SFMC levels on POD1 and diagnosed by enhanced computed tomography of the chest, abdomen, and lower extremities. Patients with asymptomatic VTE were managed with mechanical prevention, followed by anticoagulation therapy 1 week after craniotomy. RESULTS: Of the 81 patients, 33 (40.7%) were diagnosed with VTE; 31 were asymptomatic. D-dimer, SFMC, and their combination had positive predictive values of 83%, 68%, and 69%, respectively. SFMC measurement did not improve D-dimer false positives. Among 12 patients with false-negative D-dimer results, SFMC identified VTE in 3; all 3 had glioblastoma with 9 having other than glioblastoma. No asymptomatic cases progressed to symptomatic VTE. CONCLUSIONS: Asymptomatic VTE frequently developed on POD1 after diffuse glioma resection, but early diagnosis prevented progression. SFMC levels can improve VTE detection in glioblastoma patients.
引用
- Osada Y, Kanamori M, Yamashita S, et al. Early Postoperative Venous Thromboembolism After Tumor Resection for Diffuse Gliomas: Diagnosis and Implications for Preventing Symptomatic Venous Thromboembolism. World Neurosurg. 2025. PMID: 41412517. doi:10.1016/j.wneu.2025.124732
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。